STOCKHOLM—The first specialist in pediatric oncology ever to hold office as President of the American Society of Clinical Oncology, Dr Michael Link — Professor of Pediatrics at Stanford University School of Medicine — explains to Peter Goodwin how techniques for treating childhood cancers can be used as models for treating adult malignancy, during the 2011 European Multidisciplinary Cancer Congress held in Stockholm where he chaired a session on “Quality of Delivered Cancer Care”.
You may also like...
ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007 16 Feb, 2007 Enzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too 24 Mar, 2013 Malaria: one baby in three protected 12 months after vaccination 21 Nov, 2012 Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations? 27 Apr, 2009
- Previous story Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab
- Next story ASCO 2012 ANNUAL MEETING: Resolving Long Debate, Study Finds Intermittent Hormonal Therapy Less Effective than Continuous Therapy in Certain Men With Advanced Prostate Cancer
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014